# A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

> **NCT03176849** · PHASE4 · COMPLETED · sponsor: **Phoenix Children's Hospital** · enrollment: 49 (actual)

## Conditions studied

- Vitamin D Deficiency
- Stem Cell Transplant Complications
- Pediatric Cancer
- Blood Disorder
- Pediatric Acute Myeloid Leukemia
- Pediatric Acute Lymphoid Leukemia
- Myelodysplastic Syndromes
- Sickle Cell Anemia in Children
- Aplastic Anemia
- Thalassemia in Children

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin D3
- **DIETARY_SUPPLEMENT:** Standard Vitamin D3 Supplementation

## Key facts

- **NCT ID:** NCT03176849
- **Lead sponsor:** Phoenix Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-01
- **Primary completion:** 2019-07-01
- **Final completion:** 2019-07-01
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03176849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03176849, "A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03176849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*